281 related articles for article (PubMed ID: 21454581)
1. Crystal structure of leukocyte Ig-like receptor LILRB4 (ILT3/LIR-5/CD85k): a myeloid inhibitory receptor involved in immune tolerance.
Cheng H; Mohammed F; Nam G; Chen Y; Qi J; Garner LI; Allen RL; Yan J; Willcox BE; Gao GF
J Biol Chem; 2011 May; 286(20):18013-25. PubMed ID: 21454581
[TBL] [Abstract][Full Text] [Related]
2. Expression, purification, and refolding of the myeloid inhibitory receptor leukocyte immunoglobulin-like receptor-5 for structural and ligand identification studies.
Garner LI; Salim M; Mohammed F; Willcox BE
Protein Expr Purif; 2006 Jun; 47(2):490-7. PubMed ID: 16406677
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures of the two membrane-proximal Ig-like domains (D3D4) of LILRB1/B2: alternative models for their involvement in peptide-HLA binding.
Nam G; Shi Y; Ryu M; Wang Q; Song H; Liu J; Yan J; Qi J; Gao GF
Protein Cell; 2013 Oct; 4(10):761-70. PubMed ID: 23955630
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of LIR-2 (ILT4) at 1.8 A: differences from LIR-1 (ILT2) in regions implicated in the binding of the Human Cytomegalovirus class I MHC homolog UL18.
Willcox BE; Thomas LM; Chapman TL; Heikema AP; West AP; Bjorkman PJ
BMC Struct Biol; 2002 Oct; 2():6. PubMed ID: 12390682
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2).
Chapman TL; Heikema AP; West AP; Bjorkman PJ
Immunity; 2000 Nov; 13(5):727-36. PubMed ID: 11114384
[TBL] [Abstract][Full Text] [Related]
6. LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets.
Xiang Z; Yin X; Wei L; Peng M; Zhu Q; Lu X; Guo J; Zhang J; Li X; Zou Y
Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397424
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor.
Willcox BE; Thomas LM; Bjorkman PJ
Nat Immunol; 2003 Sep; 4(9):913-9. PubMed ID: 12897781
[TBL] [Abstract][Full Text] [Related]
8. LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidence.
Ryu M; Chen Y; Qi J; Liu J; Fan Z; Nam G; Shi Y; Cheng H; Gao GF
PLoS One; 2011 Apr; 6(4):e19245. PubMed ID: 21559424
[TBL] [Abstract][Full Text] [Related]
9. Killer cell Ig-like receptor and leukocyte Ig-like receptor transgenic mice exhibit tissue- and cell-specific transgene expression.
Belkin D; Torkar M; Chang C; Barten R; Tolaini M; Haude A; Allen R; Wilson MJ; Kioussis D; Trowsdale J
J Immunol; 2003 Sep; 171(6):3056-63. PubMed ID: 12960331
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of myeloid cell activating receptor leukocyte Ig-like receptor A2 (LILRA2/ILT1/LIR-7) domain swapped dimer: molecular basis for its non-binding to MHC complexes.
Chen Y; Gao F; Chu F; Peng H; Zong L; Liu Y; Tien P; Gao GF
J Mol Biol; 2009 Feb; 386(3):841-53. PubMed ID: 19230061
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection.
Brown DP; Jones DC; Anderson KJ; Lapaque N; Buerki RA; Trowsdale J; Allen RL
BMC Immunol; 2009 Oct; 10():56. PubMed ID: 19860908
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte immunoglobulin-like receptor B1 and B4 (LILRB1 and LILRB4): Highly sensitive and specific markers of acute myeloid leukemia with monocytic differentiation.
Churchill HRO; Fuda FS; Xu J; Deng M; Zhang CC; An Z; Zhang N; Chen P; Bergstrom C; Kansagra A; Collins R; John S; Koduru P; Chen W
Cytometry B Clin Cytom; 2021 Jul; 100(4):476-487. PubMed ID: 32918786
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d).
Shiroishi M; Kuroki K; Rasubala L; Tsumoto K; Kumagai I; Kurimoto E; Kato K; Kohda D; Maenaka K
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16412-7. PubMed ID: 17056715
[TBL] [Abstract][Full Text] [Related]
14. Characterization and functional analyses of novel chicken leukocyte immunoglobulin-like receptor subfamily B members 4 and 5.
Truong AD; Hong Y; Tran HTT; Dang HV; Nguyen VK; Pham TT; Lillehoj HS; Hong YH
Poult Sci; 2019 Dec; 98(12):6989-7002. PubMed ID: 31376355
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin-like transcript 3 is expressed by myeloid-derived suppressor cells and correlates with survival in patients with non-small cell lung cancer.
de Goeje PL; Bezemer K; Heuvers ME; Dingemans AC; Groen HJ; Smit EF; Hoogsteden HC; Hendriks RW; Aerts JG; Hegmans JP
Oncoimmunology; 2015 Jul; 4(7):e1014242. PubMed ID: 26140237
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the ectodomain of human FcalphaRI.
Ding Y; Xu G; Yang M; Yao M; Gao GF; Wang L; Zhang W; Rao Z
J Biol Chem; 2003 Jul; 278(30):27966-70. PubMed ID: 12783876
[TBL] [Abstract][Full Text] [Related]
17. Channel catfish leukocyte immune-type receptors contain a putative MHC class I binding site.
Stafford JL; Bengtén E; Du Pasquier L; Miller NW; Wilson M
Immunogenetics; 2007 Jan; 59(1):77-91. PubMed ID: 17149620
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the human monocyte-activating receptor, "Group 2" leukocyte Ig-like receptor A5 (LILRA5/LIR9/ILT11).
Shiroishi M; Kajikawa M; Kuroki K; Ose T; Kohda D; Maenaka K
J Biol Chem; 2006 Jul; 281(28):19536-44. PubMed ID: 16675463
[TBL] [Abstract][Full Text] [Related]
19. The Role of Leukocyte Immunoglobulin-Like Receptors Focusing on the Therapeutic Implications of the Subfamily B2.
Hu Y; Lu X; Qiu W; Liu H; Wang Q; Chen Y; Liu W; Feng F; Sun H
Curr Drug Targets; 2022; 23(15):1430-1452. PubMed ID: 36017847
[TBL] [Abstract][Full Text] [Related]
20. LILRB4 ITIMs mediate the T cell suppression and infiltration of acute myeloid leukemia cells.
Li Z; Deng M; Huang F; Jin C; Sun S; Chen H; Liu X; He L; Sadek AH; Zhang CC
Cell Mol Immunol; 2020 Mar; 17(3):272-282. PubMed ID: 31700117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
